Evaluation of radiographic predictors of left heart enlargement in dogs with known or suspected cardiovascular disease
- PMID: 33439529
- DOI: 10.1111/vru.12949
Evaluation of radiographic predictors of left heart enlargement in dogs with known or suspected cardiovascular disease
Abstract
Radiographic assessment of heart size is important for clinical management of dogs with cardiovascular disease (CVDz). We sought to compare the ability of vertebral heart size (VHS), vertebral left atrial size (VLAS), and radiologists' assessment of left atrial size (RadLAE) to predict echocardiographic left atrial size (EchoLAE), an important marker of left heart disease severity. We also compared the ability of VHS and VLAS to predict echocardiographic criteria for ACVIM stage B2 (EchoB2) in dogs with myxomatous mitral valve disease (MMVD). This prospective observational study enrolled 183 dogs with known or suspected CVDz that had an echocardiographic examination and thoracic radiographs obtained within 24 h. Compared to increased VHS, VLAS >2.3 was a more accurate predictor of EchoLAE (P = .002). VLAS >2.3 and RadLAE (both P <.0001) were independently associated with EchoLAE but VHS was not (P = .45). Optimal cutoffs for VLAS and VHS to predict EchoLAE were >2.3 vertebrae (sensitivity [Sn] = 90.3%, specificity [Sp] = 73.6%) and >11.1 vertebrae (Sn = 75.8%, Sp = 76.0%), respectively. Diagnostic accuracy of VLAS (AUC 0.84, 95% CI 0.73-0.92) and VHS (AUC 0.78, 95% CI 0.66-0.88) to predict EchoB2 in dogs with subclinical MMVD (n = 64) were not significantly different (P = .17). Results demonstrate that VLAS and RadLAE were superior indicators of EchoLAE compared to VHS in dogs with known or suspected CVDz. Both VLAS and VHS are useful predictors of EchoB2 in dogs with subclinical MMVD. When echocardiography is unavailable, VLAS represents a useful radiographic measurement to aid clinical management of dogs with known or suspected CVDz.
Keywords: cardiac silhouette; echocardiography; left atrium; mitral valve disease.
© 2021 American College of Veterinary Radiology.
References
REFERENCES
-
- Keene BW, Atkins CE, Bonagura JD, Fox PR, Häggström J, Fuentes VL. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33(3):1127-1140.
-
- Malcolm EL, Visser LC, Phillips KL, Johnson LR. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease. J Am Vet Med Assoc. 2018;253(8):1038-1045.
-
- Stepien RL, Rak MB, Blume LM. Use of radiographic measurements to diagnose stage B2 preclinical myxomatous mitral valve disease in dogs. J Am Vet Med Assoc. 2020;256(10):1129-1136.
-
- Mikawa S, Nagakawa M, Ogi H, Akabane R, Koyama Y, Sakatani A. Use of vertebral left atrial size for staging of dogs with myxomatous valve disease. J Vet Cardiol. 2020;30:92-99.
-
- Poad MH, Manzi TJ, Oyama MA, Gelzer AR. Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease. J Vet Intern Med. 2020;34(5):1728-1733.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources